Correlation Between Genmab AS and Demant AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Demant AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Demant AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Demant AS, you can compare the effects of market volatilities on Genmab AS and Demant AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Demant AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Demant AS.

Diversification Opportunities for Genmab AS and Demant AS

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Demant is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Demant AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Demant AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Demant AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Demant AS has no effect on the direction of Genmab AS i.e., Genmab AS and Demant AS go up and down completely randomly.

Pair Corralation between Genmab AS and Demant AS

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Demant AS. In addition to that, Genmab AS is 1.22 times more volatile than Demant AS. It trades about -0.03 of its total potential returns per unit of risk. Demant AS is currently generating about 0.15 per unit of volatility. If you would invest  25,660  in Demant AS on September 3, 2024 and sell it today you would earn a total of  1,260  from holding Demant AS or generate 4.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Demant AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Demant AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Demant AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Demant AS is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Genmab AS and Demant AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Demant AS

The main advantage of trading using opposite Genmab AS and Demant AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Demant AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Demant AS will offset losses from the drop in Demant AS's long position.
The idea behind Genmab AS and Demant AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities